Focal lymphocytic sialadenitis and ectopic germinal centers in oral reactive lesions and primary Sjögren's syndrome: a comparative study.
Ectopic germinal centers
Focal lymphocytic sialadenitis
Immunohistochemistry
Non-Sjögren’s non-sicca patient
Oral reactive lesions
Sjögren’s syndrome
Journal
Rheumatology international
ISSN: 1437-160X
Titre abrégé: Rheumatol Int
Pays: Germany
ID NLM: 8206885
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
received:
13
04
2021
accepted:
13
07
2021
pubmed:
21
7
2021
medline:
20
7
2022
entrez:
20
7
2021
Statut:
ppublish
Résumé
Focal lymphocytic sialadenitis (FLS), an important diagnostic criterion for Sjögren's syndrome (SS) diagnosis, can also be observed when assessing minor salivary gland (mSG) biopsies from healthy asymptomatic individuals (non-SS patients). Fifty cases of primary SS (pSS group) and 31 cases of oral reactive lesions (non-SS non-sicca group) containing also typical FLS features, were assessed by morphological and immunohistochemical (CD10, CD23 and Bcl-6) analysis, aiming at the detection of GCs. All pSS cases showed FLS with focus score (FS) ≥ 1. In the non-SS non-sicca group, 12, 10 and 9 cases showed FLS with FS ≥ 1, FLS with FS < 1 and FLS associated with chronic sclerosing sialadenitis with FS < 1, respectively. The morphological analysis revealed similar frequency of GCs in pSS (20%) and non-SS non-sicca group (19%). The area (p = 0.052) and largest diameter (p = 0.245) of GCs were higher in pSS than non-SS non-sicca group. The FS and number of foci were significantly higher in pSS than non-SS non-sicca group with FS < 1. Immunohistochemistry confirmed all morphological findings (GCs showing CD23 and Bcl-6 positivity, with variable CD10 expression) and additionally in 3 and 1 cases of the pSS and non-SS non-sicca group, respectively. Moreover, another 6 and 2 cases of the pSS and non-SS non-sicca group with FS ≥ 1, respectively, showed positivity only for CD23. FLS can also be observed when assessing oral reactive lesions, which showed similar frequency of GCs with those found in pSS patients. Further studies, including functional analysis of lymphocytic populations and GCs in FLS, are encouraged.
Identifiants
pubmed: 34283264
doi: 10.1007/s00296-021-04949-6
pii: 10.1007/s00296-021-04949-6
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1411-1421Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Jonsson MV, Szodoray P, Jellestad S, Jonsson R, Skarstein K (2005) Association between circulating levels of the novel TNF family members APRIL and BAFF and lymphoid organization in primary Sjögren’s syndrome. J Clin Immunol 25(3):189–201. https://doi.org/10.1007/s10875-005-4091-5
doi: 10.1007/s10875-005-4091-5
pubmed: 15981083
Mariette X, Criswell LA (2018) Primary Sjögren’s syndrome. N Engl J Med 378(10):931–939. https://doi.org/10.1056/NEJMcp1702514
doi: 10.1056/NEJMcp1702514
pubmed: 29514034
Johnsen SJ, Berget E, Jonsson MV, Helgeland L, Omdal R, Jonsson R (2014) Evaluation of germinal center-like structures and B cell clonality in patients with primary sjögren syndrome with and without Lymphoma. J Rheumatol 41(11):2214–2222. https://doi.org/10.3899/jrheum.131527
doi: 10.3899/jrheum.131527
pubmed: 25274895
Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM et al (2017) 2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren’s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol 69(1):35–45. https://doi.org/10.1002/art.39859
doi: 10.1002/art.39859
pubmed: 27785888
Risselada AP, Looije MF, Kruize AA, Bijlsma JWJ, Van Roon JAG (2013) The role of ectopic germinal centers in the immunopathology of primary Sjögren’s syndrome: a systematic review. Semin Arthritis Rheum 42:368–376. https://doi.org/10.1016/j.semarthrit.2012.07.003
doi: 10.1016/j.semarthrit.2012.07.003
pubmed: 22995442
Jonsson MV, Skarstein K, Jonsson R, Brun JG (2007) Serological implications of germinal center-like structures in primary Sjögren’s syndrome. J Rheumatol 34:2044–2049
pubmed: 17787040
Reksten TR, Jonsson MV, Szyszko EA, Brun JG, Jonsson R, Brokstad KA (2009) Cytokine and autoantibody profiling related to histopathological features in primary Sjögren’s syndrome. Rheumatology 48(9):1102–1106. https://doi.org/10.1093/rheumatology/kep149
doi: 10.1093/rheumatology/kep149
pubmed: 19574472
Lee KE, Kang JH, Yim YR, Kim JE, Lee JW, Wen L et al (2016) The significance of ectopic germinal centers in the minor salivary gland of patients with Sjögren’s syndrome. J Korean Med Sci 31(2):190–195. https://doi.org/10.3346/jkms.2016.31.2.190
doi: 10.3346/jkms.2016.31.2.190
pubmed: 26839471
pmcid: 4729497
He J, Jin Y, Zhang X, Zhou Y, Li R, Dai Y et al (2017) Characteristics of germinal center-like structures in patients with Sjögren’s syndrome. Int J Rheum Dis 20(2):245–521. https://doi.org/10.1111/1756-185X.12856
doi: 10.1111/1756-185X.12856
pubmed: 28556615
Theander E, Vasaitis L, Baecklund E, Nordmark G, Warfvinge G, Liedholm R et al (2011) Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren’s syndrome. Ann Rheum Dis 70:1363–1368. https://doi.org/10.1136/ard.2010.144782
doi: 10.1136/ard.2010.144782
pubmed: 21715359
Sène D, Ismael S, Forien M, Charlotte F, Kaci R, Cacoub P et al (2018) Ectopic germinal center–like structures in minor salivary gland biopsy tissue predict lymphoma occurrence in patients with primary Sjögren’s syndrome. Arthritis Rheumatol 70(9):1481–1488. https://doi.org/10.1002/art.40528
doi: 10.1002/art.40528
pubmed: 29669392
Bombardieri M, Barone F, Humby F, Kelly S, McGurk M, Morgan P et al (2007) Activation-induced cytidine deaminase expression in follicular dendritic cell networks and interfollicular large B cells supports functionality of ectopic lymphoid neogenesis in autoimmune sialoadenitis and MALT lymphoma in Sjögren’s syndrome. J Immunol 179:4929–4938
doi: 10.4049/jimmunol.179.7.4929
Christodoulou MI, Kapsogeorgou EK, Moutsopoulos HM (2010) Characteristics of the minor salivary gland infiltrates in Sjögren’s syndrome. J Autoimmun 34(4):400–407. https://doi.org/10.1016/j.jaut.2009.10.004
doi: 10.1016/j.jaut.2009.10.004
pubmed: 19889514
Jonsson MV, Skarstein K (2008) Follicular dendritic cells confirm lymphoid organization in the minor salivary glands of primary Sjögren’s syndrome. J Oral Pathol Med 37(9):515–521. https://doi.org/10.1111/j.1600-0714.2008.00674.x
doi: 10.1111/j.1600-0714.2008.00674.x
pubmed: 18662248
Szyszko EA, Brokstad KA, Øijordsbakken G, Jonsson MV, Jonsson R, Skarstein K (2011) Salivary glands of primary Sjögren’s syndrome patients express factors vital for plasma cell survival. Arthritis Res Ther 13(1):1–18. https://doi.org/10.1186/ar3220
doi: 10.1186/ar3220
Haacke EA, Van Der Vegt B, Vissink A, Spijkervet FKL, Bootsma H, Kroese FGM (2017) Germinal centres in diagnostic labial gland biopsies of patients with primary Sjogren’s syndrome are not predictive for parotid MALT lymphoma development. Ann Rheum Dis 76(10):1783–1786. https://doi.org/10.1136/annrheumdis-2017-211290
doi: 10.1136/annrheumdis-2017-211290
Haacke EA, van der Vegt B, Vissink A, Spijkervet FKL, Bootsma H, Kroese FGM (2019) Germinal centers in diagnostic biopsies of patients with primary Sjögren’s Syndrome are not a risk factor for non-Hodgkin’s lymphoma but a reflection of high disease activity: comment on the article by Sène et al. Arthritis Rheumatol 71(1):170–171. https://doi.org/10.1002/art.40715
doi: 10.1002/art.40715
pubmed: 30178631
Jonsson MV, Salomonsson S, Oijordsbakken G, Skarstein K (2005) Elevated serum levels of soluble E-cadherin in patients with primary Sjögren’s syndrome. Scand J Immunol 62(6):552–559. https://doi.org/10.1111/j.1365-3083.2005.01698.x
doi: 10.1111/j.1365-3083.2005.01698.x
pubmed: 16316423
Pijpe J, Kalk WWI, van der Wal JE, Vissink A, Kluin PM, Roodenburg JLN et al (2007) Parotid gland biopsy compared with labial biopsy in the diagnosis of patients with primary Sjögren’s syndrome. Rheumatology 46(2):335–341. https://doi.org/10.1093/rheumatology/kel266
doi: 10.1093/rheumatology/kel266
pubmed: 16891656
Delli K, Haacke EA, Kroese FGM, Pollard RP, Ihrler S, Van Der Vegt B et al (2016) Towards personalised treatment in primary Sjögren’s syndrome: baseline parotid histopathology predicts responsiveness to rituximab treatment. Ann Rheum Dis 75(11):1933–1938. https://doi.org/10.1136/annrheumdis-2015-208304
doi: 10.1136/annrheumdis-2015-208304
pubmed: 26757748
Nakshbandi U, Haacke EA, Bootsma H, Vissink A, Spijkervet FKL, van der Vegt B et al (2020) Bcl-6 for identification of germinal centres in salivary gland biopsies in primary Sjögren’s syndrome. Oral Dis 26(3):707–710. https://doi.org/10.1111/odi.13276
doi: 10.1111/odi.13276
pubmed: 31912593
pmcid: 7187171
Daridon C, Pers JO, Devauchelle V, Martins-Carvalho C, Hutin P, Pennec YL et al (2006) Identification of transitional type II B cells in the salivary glands of patients with Sjögren’s syndrome. Arthritis Rheum 54(7):2280–2288. https://doi.org/10.1002/art.21936
doi: 10.1002/art.21936
pubmed: 16802367
Le Pottier L, Devauchelle V, Fautrel A, Daridon C, Saraux A, Youinou P et al (2009) Ectopic germinal centers are rare in Sjogren’s syndrome salivary glands and do not exclude autoreactive B cells. J Immunol 182(6):3540–3547. https://doi.org/10.4049/jimmunol.0803588
doi: 10.4049/jimmunol.0803588
pubmed: 19265132
Fei Y, Zhang W, Lin D, Wu C, Li M, Zhao Y et al (2014) Clinical parameter and Th17 related to lymphocytes infiltrating degree of labial salivary gland in primary Sjögren’s syndrome. Clin Rheumatol 33(4):523–529. https://doi.org/10.1007/s10067-013-2476-z
doi: 10.1007/s10067-013-2476-z
pubmed: 24420723
Scott J (1980) Qualitative and quantitative observations on the histology of human labial salivary glands obtained post mortem. J Biol Buccale 8:187–200
pubmed: 6937456
Syrjänen S (1984) Age-related changes in structure of labial minor salivary glands. Age Ageing 13(3):159–165. https://doi.org/10.1093/ageing/13.3.159
doi: 10.1093/ageing/13.3.159
pubmed: 6731173
De Wilde PC, Baak JP, van Houwelingen JC, Kater L, Slootweg PJ (1986) Morphometric study of histological changes in sublabial salivary glands due to aging process. J Clin Pathol 39(4):406–417. https://doi.org/10.1136/jcp.39.4.406
doi: 10.1136/jcp.39.4.406
pubmed: 3700674
pmcid: 499837
Kurashima C, Hirokawa K (1986) Age-related increase of focal lymphocytic infiltration in the human submandibular glands. J Oral Pathol 15(3):172–178. https://doi.org/10.1111/j.1600-0714.1986.tb00601.x
doi: 10.1111/j.1600-0714.1986.tb00601.x
pubmed: 3084742
Segerberg-Konttinen M, Konttinen YT, Bergroth V (1986) Focus score in the diagnosis of Sjögren’s syndrome. Scand J Rheumatol 61:47–51
Takeda Y, Komori A (1986) Focal lymphocytic infiltration in the human labial salivary glands: a postmortem study. J Oral Pathol 15(2):83–86. https://doi.org/10.1111/j.1600-0714.1986.tb00582.x
doi: 10.1111/j.1600-0714.1986.tb00582.x
pubmed: 3083067
Segerberg-Konttinen M (1989) A postmortem study of focal adenitis in salivary and lacrimal glands. J Autoimmun 2(4):553–558. https://doi.org/10.1016/0896-8411(89)90188-1
doi: 10.1016/0896-8411(89)90188-1
pubmed: 2789657
Vered M, Buchner A, Haimovici E, Hiss Y, Dayan D (2001) Focal lymphocytic infiltration in aging human palatal salivary glands: a comparative study with labial salivary glands. J oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol 30(1):7–11. https://doi.org/10.1034/j.1600-0714.2001.300102.x
doi: 10.1034/j.1600-0714.2001.300102.x
Radfar L, Kleiner DE, Fox PC, Pillemer SR (2002) Prevalence and clinical significance of lymphocytic foci in minor salivary glands of healthy volunteers. Arthritis Rheum 47(5):520–524. https://doi.org/10.1002/art.10668
doi: 10.1002/art.10668
pubmed: 12382301
McIntosh GG, Lodge AJ, Watson P, Hall G, Wood K, Anderson JJ, Angus B, Horne CH, Milton ID (1999) NCL-CD10-270: a new monoclonal antibody recognizing CD10 in paraffin-embedded tissue. Am J Pathol 154(1):77–82. https://doi.org/10.1016/S0002-9440(10)65253-4
doi: 10.1016/S0002-9440(10)65253-4
pubmed: 9916921
pmcid: 1853426
Rangel ALCA, León JE, Jorge J, Lopes MA, Vargas PA (2008) Oncocytic metaplasia in inflammatory fibrous hyperplasia: Histopathological and immunohistochemical analysis. Med Oral Patol Oral Cir Bucal 13:151–155
Fisher BA, Jonsson R, Daniels T, Bombardieri M, Brown RM, Morgan P et al (2017) Standardisation of labial salivary gland histopathology in clinical trials in primary Sjögren’s syndrome. Ann Rheum Dis 76(7):1161–1168. https://doi.org/10.1136/annrheumdis-2016-210448
doi: 10.1136/annrheumdis-2016-210448
pubmed: 27965259
Allen CDC, Cyster JG (2008) Follicular dendritic cell networks of primary follicles and germinal centers: phenotype and function. Semin Immunol 20(1):14–25. https://doi.org/10.1016/j.smim.2007.12.001
doi: 10.1016/j.smim.2007.12.001
pubmed: 18261920
pmcid: 2366796
Kurshumliu F, Sadiku-Zehri F, Qerimi A, Vela Z, Jashari F, Bytyci S et al (2019) Divergent immunohistochemical expression of CD21 and CD23 by follicular dendritic cells with increasing grade of follicular lymphoma. World J Surg Oncol 17(1):115. https://doi.org/10.1186/s12957-019-1659-8
doi: 10.1186/s12957-019-1659-8
pubmed: 31269981
pmcid: 6610797
Maguer-Satta V, Besançon R, Bachelard-Cascales E (2011) Concise review: neutral endopeptidase (CD10): a multifaceted environment actor in stem cells, physiological mechanisms, and cancer. Stem Cells 29(3):389–396. https://doi.org/10.1002/stem.592
doi: 10.1002/stem.592
pubmed: 21425402
Beaulieu AM, Sant’Angelo DB (2011) The BTB-ZF family of transcription factors: key regulators of lineage commitment and effector function development in the immune system. J Immunol 187(6):2841–2847. https://doi.org/10.4049/jimmunol.1004006
doi: 10.4049/jimmunol.1004006
pubmed: 21900183
Kim JR, Lim HW, Kang SG, Hillsamer P, Kim CH (2005) Human CD57+ germinal center-T cells are the major helpers for GC-B cells and induce class switch recombination. BMC Immunol 6:3. https://doi.org/10.1186/1471-2172-6-3
doi: 10.1186/1471-2172-6-3
pubmed: 15694005
pmcid: 548684
Carubbi F, Alunno A, Cipriani P, Bartoloni E, Baldini C, Quartuccio L et al (2015) A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sjögren’s syndrome. Lupus 24(3):315–320. https://doi.org/10.1177/0961203314554251
doi: 10.1177/0961203314554251
pubmed: 25297554
Risselada AP, Kruize AA, Goldschmeding R, Lafeber FPJG, Bijlsma JWJ, van Roon JAG (2014) The prognostic value of routinely performed minor salivary gland assessments in primary Sjögren’s syndrome. Ann Rheum Dis 73(8):1537–1540. https://doi.org/10.1136/annrheumdis-2013-204634
doi: 10.1136/annrheumdis-2013-204634
pubmed: 24525912
Haacke EA, Bootsma H, Spijkervet FKL, Visser A, Vissink A, Kluin PM et al (2017) FcRL4(+) B-cells in salivary glands of primary Sjögren’s syndrome patients. J Autoimmun 81:90–98. https://doi.org/10.1016/j.jaut.2017.03.012
doi: 10.1016/j.jaut.2017.03.012
pubmed: 28390747
Ciccia F, Guggino G, Rizzo A, Bombardieri M, Raimondo S, Carubbi F et al (2015) Interleukin (IL)-22 receptor 1 is over-expressed in primary Sjogren’s syndrome and Sjögren-associated non-Hodgkin lymphomas and is regulated by IL-18. Clin Exp Immunol 181(2):219–229. https://doi.org/10.1111/cei.12643
doi: 10.1111/cei.12643
pubmed: 25880879
pmcid: 4516437
Johnsen SJA, Gudlaugsson E, Skaland I, Janssen EAM, Jonsson MV, Helgeland L et al (2016) Low protein A20 in minor salivary glands is associated with lymphoma in primary Sjögren’s syndrome. Scand J Immunol 83(3):181–187. https://doi.org/10.1111/sji.12405
doi: 10.1111/sji.12405
pubmed: 26679293
Ussmüller J, Reinecke T, Donath K, Jaehne M (2002) Chronic myoepithelial sialadenitis - symptomatology, clinical signs, differential diagnostics. Laryngorhinootologie 81(2):111–117. https://doi.org/10.1055/s-2002-23111
doi: 10.1055/s-2002-23111
pubmed: 11914948
Jonsson MV, Theander E, Jonsson R (2012) Predictors for the development of non-Hodgkin lymphoma in primary Sjögren’s syndrome. Presse Med 41(9 pt 2):e511-516. https://doi.org/10.1016/j.lpm.2012.05.025
doi: 10.1016/j.lpm.2012.05.025
pubmed: 22867948
Ioannidis JP, Vassiliou VA, Moutsopoulos HM (2002) Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren’s syndrome. Arthritis Rheum 46(3):741–747. https://doi.org/10.1002/art.10221
doi: 10.1002/art.10221
pubmed: 11920410
Theander E, Henriksson G, Ljungberg O, Mandl T, Manthorpe R, Jacobsson LT (2006) Lymphoma and other malignancies in primary Sjögren’s syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis 65(6):796–803. https://doi.org/10.1136/ard.2005.041186
doi: 10.1136/ard.2005.041186
pubmed: 16284097
Skopouli FN, Dafni U, Ioannidis JP, Moutsopoulos HM (2000) Clinical evolution, and morbidity and mortality of primary Sjögren’s syndrome. Semin Arthritis Rheum 29(5):296–304. https://doi.org/10.1016/s0049-0172(00)80016-5
doi: 10.1016/s0049-0172(00)80016-5
pubmed: 10805354
Voulgarelis M, Dafni UG, Isenberg DA, Moutsopoulos HM (1999) Malignant lymphoma in primary Sjögren’s syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren’s Syndrome. Arthritis Rheum 42(8):1765–1772. https://doi.org/10.1002/1529-0131(199908)42:8%3c1765::AIDANR28%3e3.0.CO;2-
doi: 10.1002/1529-0131(199908)42:8<1765::AIDANR28>3.0.CO;2-
pubmed: 10446879
Voulgarelis M, Ziakas PD, Papageorgiou A, Baimpa E, Tzioufas AG, Moutsopoulos HM (2012) Prognosis and outcome of non-Hodgkin lymphoma in primary Sjögren syndrome. Medicine 91(1):1–9. https://doi.org/10.1097/MD.0b013e31824125e4
doi: 10.1097/MD.0b013e31824125e4
pubmed: 22198497
Tzioufas AG, Manoussakis MN, Costello R, Silis M, Papadopoulos NM, Moutsopoulos HM (1986) Cryoglobulinemia in autoimmune rheumatic diseases. Evidence of circulating monoclonal cryoglobulins in patients with primary Sjögren’s syndrome. Arthritis Rheum 29(9):1098–1104. https://doi.org/10.1002/art.1780290907
doi: 10.1002/art.1780290907
pubmed: 3489468
Hernández JA, Olivé A, Ribera JM, Tena X, Cuxart A, Feliu E (1996) Probability of the development of non-Hodgkin’s lymphoma in primary Sjögren’s syndrome. Scand J Rheum 25(6):396–397. https://doi.org/10.3109/03009749609065654
doi: 10.3109/03009749609065654
pubmed: 8996477
Szodoray P, Alex P, Jonsson MV, Knowlton N, Dozmorov I, Nakken B et al (2005) Distinct profiles of Sjögren’s syndrome patients with ectopic salivary gland germinal centers revealed by serum cytokines and BAFF. Clin Immunol 117(2):168–176. https://doi.org/10.1016/j.clim.2005.06.016
doi: 10.1016/j.clim.2005.06.016
pubmed: 16126006
Gatumu MK, Jonsson MV, Øijordsbakken G, Skarstein K (2009) Nuclear BCL10 in primary Sjögren’s syndrome. J Oral Pathol Med 38(6):501–507. https://doi.org/10.1111/j.1600-0714.2009.00757.x
doi: 10.1111/j.1600-0714.2009.00757.x
pubmed: 19298243
Manoussakis MN, Boiu S, Korkolopoulou P, Kapsogeorgou EK, Kavantzas N, Ziakas P et al (2007) Rates of infiltration by macrophages and dendritic cells and expression of interleukin-18 and interleukin-12 in the chronic inflammatory lesions of Sjögren’s syndrome: correlation with certain features of immune hyperactivity and factors associated with h. Arthritis Rheum 56(12):3977–3988. https://doi.org/10.1002/art.23073
doi: 10.1002/art.23073
pubmed: 18050195